Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NSC756093

Copy Product Info
🥰Excellent
Catalog No. T24557Cas No. 1629908-92-4
Alias NSC-756093, NSC 756093

NSC756093 potentially inhibits GBP1:PIM1 interaction. NSC756093 can be used in ovarian cancer studies.

NSC756093

NSC756093

Copy Product Info
🥰Excellent
Purity: 99.92%
Catalog No. T24557Alias NSC-756093, NSC 756093Cas No. 1629908-92-4
NSC756093 potentially inhibits GBP1:PIM1 interaction. NSC756093 can be used in ovarian cancer studies.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$39In StockIn Stock
5 mg$93In StockIn Stock
10 mg$159In StockIn Stock
25 mg$347In StockIn Stock
50 mg$516In StockIn Stock
100 mg$736In StockIn Stock
500 mg$1,480In StockIn Stock
1 mL x 10 mM (in DMSO)$119In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.92%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

NSC756093 AI Summary
NSC756093 inhibits the interaction between GBP1 and PIM1 at a concentration of 100 nM, as determined by SPR analysis, resulting in a 65.0% inhibition. It exhibits synergistic antiproliferative activity against human SCC25 cells, reducing cell viability and colony formation units when preincubated at varying concentrations followed by irradiation with different doses of ionizing radiation. The compound also induces cell cycle arrest at the G2/M phase and promotes apoptosis in both SCC25 and FADU cells, enhancing its bioactivity in inhibiting cell growth and promoting cell death. Additionally, NSC756093 shows inhibition of cell migration in both cell lines when combined with irradiation and demonstrates selectivity towards FADU cells based on colony formation unit reduction and cell viability, while also exhibiting varying effects on SCC25 cells in the presence of ionizing radiation..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
NSC756093 potentially inhibits GBP1:PIM1 interaction. NSC756093 can be used in ovarian cancer studies.
SynonymsNSC-756093, NSC 756093
Chemical Properties
Molecular Weight337.37
FormulaC20H19NO4
Cas No.1629908-92-4
SmilesCOc1ccc2C(C3=C(COC3=O)N(CCO)c2c1)c1ccccc1
Relative Density.1.35 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 55 mg/mL (163.03 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9641 mL14.8205 mL29.6410 mL148.2052 mL
5 mM0.5928 mL2.9641 mL5.9282 mL29.6410 mL
10 mM0.2964 mL1.4821 mL2.9641 mL14.8205 mL
20 mM0.1482 mL0.7410 mL1.4821 mL7.4103 mL
50 mM0.0593 mL0.2964 mL0.5928 mL2.9641 mL
100 mM0.0296 mL0.1482 mL0.2964 mL1.4821 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy NSC756093 | purchase NSC756093 | NSC756093 cost | order NSC756093 | NSC756093 chemical structure | NSC756093 formula | NSC756093 molecular weight